Document Preview Unavailable

Inhibition of the IL-17A axis Protects against Immune-related Adverse Events while Supporting Checkpoint Inhibitor Anti-tumor Efficacy

Lechner, Melissa G; Patel, Anushi Y; Hugo, Willy; Angell, Trevor E; Cheng, Mandy I; et al.  bioRxiv, Jan 21, 2022.

You might have access to this document